for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare Sector

BRIEF-Scancell Holdings Says Initiated Research Programme To Develop Vaccine For Covid-19

April 24 (Reuters) - Scancell Holdings PLC:

* SCANCELL HOLDINGS - INITIATED A RESEARCH PROGRAMME TO DEVELOP A VACCINE FOR COVID-19

* SCANCELL HOLDINGS - INITIAL RESEARCH IS UNDERWAY AND ANTICIPATES INITIATING A PHASE 1 CLINICAL TRIAL IN Q1 2021, SUBJECT TO FUNDING

* SCANCELL HOLDINGS - ACTIVELY SEEKING DEVELOPMENT PARTNERS AND ADDITIONAL FUNDING TO SUPPORT RAPID DEVELOPMENT OF VACCINE Source text for Eikon: Further company coverage:

Nuestros Estándares: Los principios Thomson Reuters.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up